Albuquerque, NM, United States of America

John D Maynard

USPTO Granted Patents = 19 

Average Co-Inventor Count = 3.9

ph-index = 16

Forward Citations = 1,831(Granted Patents)


Company Filing History:


Years Active: 2003-2014

Loading Chart...
19 patents (USPTO):

Title: Innovations of John D. Maynard: Pioneering Advances in Tissue Analysis

Introduction

John D. Maynard, based in Albuquerque, NM, is an esteemed inventor with a remarkable portfolio that includes 19 patents. His groundbreaking work focuses on non-invasive methods for analyzing tissue states, with particular applications in medical diagnostics.

Latest Patents

Among his notable inventions is a patented method and apparatus designed to compensate for melanin and hemoglobin variation in the determination of glycation end-products or disease states using tissue fluorescence. This innovative method involves illuminating a portion of the skin with excitation light. The emitted light due to fluorescence is then detected, allowing for the assessment of the tissue state while mitigating the effects of time-varying signals like those caused by hemoglobin.

Additionally, Maynard has developed apparatuses for the non-invasive determination of alcohol concentration in blood or tissue using Raman spectroscopy. This method involves illuminating tissue and analyzing the Raman scattered light to derive alcohol concentration. The technology prides itself on being highly optimized, providing consistent measurement while incorporating correction techniques for accuracy, making it a significant advancement in the medical field.

Career Highlights

Throughout his career, John D. Maynard has made significant contributions in the innovation landscape, having worked with esteemed companies such as Veralight, Inc. and TruTouch Technologies, Inc. His work has played a critical role in enhancing non-invasive medical diagnostic techniques.

Collaborations

Maynard has collaborated with notable colleagues, including Robert D. Johnson and Trent D. Ridder. Together, they have contributed to advancements in imaging and diagnostic technologies, combining their expertise to push the boundaries of non-invasive diagnostics.

Conclusion

John D. Maynard's contributions to the field of tissue analysis through his innovative patents have paved the way for significant advancements in medical diagnostics. His work exemplifies the importance of innovation in improving health outcomes and represents a significant step towards non-invasive diagnostic techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…